Drug combination therapy of systemic lupus erythematosus

Springer Semin Immunopathol. 1994;16(2-3):295-311. doi: 10.1007/BF00197523.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cyclosporine / administration & dosage*
  • Cyclosporine / adverse effects
  • Dexamethasone / administration & dosage*
  • Dexamethasone / adverse effects
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoglobulin G / blood
  • Interleukin-2 / blood
  • Kidney Function Tests
  • Lupus Erythematosus, Systemic / drug therapy*
  • Lupus Erythematosus, Systemic / mortality
  • Male
  • Methotrexate / administration & dosage*
  • Methotrexate / adverse effects
  • Receptors, Interleukin-2 / analysis

Substances

  • Immunoglobulin G
  • Interleukin-2
  • Receptors, Interleukin-2
  • Dexamethasone
  • Cyclosporine
  • Methotrexate